Vanda Pharmaceuticals Inc.
TREATMENT OF CIRCADIAN RHYTHM DISORDERS
Last updated:
Abstract:
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
Status:
Application
Type:
Utility
Filling date:
15 Feb 2022
Issue date:
2 Jun 2022